Tk0102 1005 — New York, New York

Tk0102 1005 is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Tk0102 1005 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Thymidine Kinase 2 Deficiency.

Sponsors: UCB BIOSCIENCES, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tk0102 1005?

Tk0102 1005 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tk0102 1005 conducted?

Tk0102 1005 has 1 clinical trials on record, with 1 currently active. Their work covers Thymidine Kinase 2 Deficiency.

Is Tk0102 1005 accredited by Crixeo Health?

Tk0102 1005 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tk0102 1005?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.